Actual Medicinal Product (AMP) Pentasa 500mg modified-release tablets (Ferring Pharmaceuticals Ltd)
Stability Information
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Store in airtight containers and protect from light. Discolouration (which is harmless) may occur outside packaging. Maximum one week in MCA.
- Generic
- Mesalazine
- Formulation
- Mesalazine 500mg modified-release tablets
-
Mesalazine
-
Mesalazine 500mg modified-release tablets
-
Pentasa 500mg modified-release tablets (Ferring Pharmaceuticals Ltd)
-
-
Pentasa 500mg modified-release tablets (Necessity Supplies Ltd)